CEO, Cell and Gene Therapy Catapult
Keith has established a team of over 120 cell and gene therapy experts in state-of-the-art laboratories in London and is now building a large-scale manufacturing centre.
Keith joined the Cell and Gene Therapy Catapult from the Scottish Blood Transfusion Service where he was National Director, and focused on modernising the blood supply from vein-to-vein and expanding into cell and gene therapy. Prior to this he held various positions in Biotechnology companies. He was at various times, Managing Director of Bioscot, one of Scotland’s first Biotechnology companies, Vice President of Serologicals Diagnostics Operations, then Vice President of Global Manufacturing. He has been Chairman of the UK Blood Forum, a Director of the European Blood Alliance and Treasurer of the International Plasma Fractionators Association. In 1993 when at Bioscot, Keith received the Queen’s Award for export.
Keith holds first and second degrees in biological sciences and applied genetics from Birmingham University along with an MBA from Edinburgh University.